Rip Ballou, GSK Global Vaccines (EP.14)

Rip Ballou, MD, VP & Head, GSK Global Vaccines US R&D Center and BHI President & CEO Rich Bendis discuss GSK's move to the BioHealth Capital Region, their Vaccines Portfolio/Future, and the importance of succeeding in the industry today.

Episode metadata supplied by the publisher feed · Published Jul 2, 2018

Embed this episode

Attribution link and audio player

NOW PLAYING

Rip Ballou, GSK Global Vaccines (EP.14)

0:00 25:03

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of BioTalk with Rich Bendis?

This episode is 25 minutes long.

When was this BioTalk with Rich Bendis episode published?

This episode was published on July 2, 2018.

Can I download this BioTalk with Rich Bendis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!